PROBLEM TO BE SOLVED: To provide a process and assay for determining the neurological condition in a subject whereby the level of one or more neuroactive biomarkers is measured in a sample obtained from the subject.SOLUTION: The process and assay includes measurement of multiple neuroactive biomarkers for synergistic determination of a neurological condition such as neurological damage due to injury, disease, contact with a chemical compound, or other sources. The first neuroactive biomarker includes UCH-L1, GFAP, NSE, NeuN, CNPase, CAM-1, iNOS, MAP-1, MAP-2, SBDP145, SBDP120, βIII-tubulin, a synaptic protein, neuroserpin, α-internexin, LC3, neurofascin, EAAT, DAT, nestin, cortin-1, CRMP, ICAM-1, ICAM-2, ICAM-5, VCAM-1, NCAM-1, etc.
BIOMARKER ASSAY OF NEUROLOGICAL CONDITION